LaurenMiller Forbes

Associate

Washington + 1.202.879.3798

Lauren Miller Forbes practices antitrust and competition law, focusing on mergers, nonmerger investigations, and antitrust counseling. She has represented clients from a broad range of industries — including aviation, home products, semiconductors, building materials, pharmaceuticals, and medical devices — before the U.S. Department of Justice (DOJ), the Federal Trade Commission (FTC), and state antitrust enforcers.

Lauren counsels buyers and sellers in domestic and international transactions at every stage of the deal process, from premerger planning to regulatory filings, DOJ and FTC investigations, and litigation. She served as antitrust counsel to General Electric in its $3.4 billion sale of GE Water & Process Technologies to Suez, Tokyo Electron in its proposed merger with Applied Materials, and Baxter International's successful acquisition of generic pharmaceuticals company Claris Injectables; she also defended Electrolux Corporation in DOJ's challenge to the proposed acquisition of General Electric's appliance business.

Lauren advises clients on a wide range of merger and nonmerger topics, including competitor collaborations, monopolization claims, and potential government investigations. She has successfully defended a building materials manufacturer against price-fixing claims levied by both private plaintiffs and government enforcers and advised a medical device manufacturer on monopolization issues. She has also conducted internal investigations and developed antitrust compliance programming for major automotive, pharmaceutical, and consumer goods clients.

Lauren is a member of the American Bar Association's Section of Antitrust Law and writes regularly on antitrust issues for that organization. She is also a member of the Virginia State Bar and the District of Columbia Bar.

Experience

  • Misonix merges with BioventusJones Day represented Misonix, Inc. (Nasdaq: MSON) in its acquisition by Bioventus Inc. (Nasdaq: BVS).
  • Signature Aviation sells Global Engine Services business to StandardAero for $230 millionJones Day advised Signature Aviation plc, a market-leading provider of global aviation support services, in the $230 million sale of the Engine Repair and Overhaul (ERO) business to StandardAero, a portfolio company owned by The Carlyle Group and a leading provider of maintenance, repair, and overhaul services.
  • OMNOVA acquired by Synthomer plc for $824 millionJones Day advised OMNOVA Solutions Inc. in its $824 million acquisition by Synthomer plc, a United Kingdom-based specialty chemical company.
  • BBA Aviation sells Ontic for $1.365 billionJones Day advised BBA Aviation plc ("BBA") in the sale of its Ontic business to an investment fund affiliated with CVC Capital Partners for $1.365 billion.
  • Milliken & Company acquires PolartecJones Day advised Milliken & Company in its acquisition of Polartec, a strong global brand known for its innovative performance textiles for outdoor and military apparel, from Versa Capital Management, LLC.
  • Milliken & Company acquires Andover Healthcare, Inc. and Andover Resources, Inc.Jones Day advised Milliken & Company, an industrial manufacturer that is active in a breadth of disciplines, including specialty chemical, floor covering, performance and protective textile materials, in connection with the acquisition of Andover Healthcare, Inc. and Andover Resources, Inc., leading manufacturers of cohesive bandages and tapes for healthcare, animal health, and sports medicine industries.
  • Newell Brands sells Process Solutions to One Rock Capital Partners, LLC for $500 millionJones Day advised Newell Brands Inc. in the sale of its Process Solutions business to One Rock Capital Partners, LLC for $500 million in cash.
  • USG acquired by Gebr. Knauf for $7 billionJones Day advised USG Corporation in the acquisition by Gebr. Knauf KG ("Knauf") of all of the outstanding shares of USG in a transaction valued at $7 billion.
  • Babcock & Wilcox sells MEGTEC and Universal for $130 millionJones Day advised Babcock & Wilcox Enterprises Inc. in the $130 million sale of its Universal/Megtec businesses to Dürr AG.
  • Yale New Haven Health adds Milford Health & Medical to its health systemJones Day served as antitrust counsel to Yale New Haven Health System regarding its Bridgeport Hospital’s successful acquisition of Milford Health & Medical, Inc., an acute care community hospital located in Milford, Connecticut.
  • ProMedica Health and Welltower complete acquisition of HCR ManorCare and Quality Care properties for $4.4 billionJones Day served as lead antitrust counsel for both ProMedica Health Systems, Inc. and HCR ManorCare, Inc., and co-counsel for ProMedica on other complex corporate, bankruptcy, and regulatory issues, in this first of its kind partnership and acquisition.
  • Newell Brands sells Rawlings Sporting Goods Company, Inc. for $395 millionJones Day advised Newell Brands Inc. in the $395 million sale of Rawlings Sporting Goods Company, Inc. to Seidler Equity Partners and Major League Baseball.
  • Newell Brands sells The Waddington Group to Novolex for approximately $2.3 billionJones Day advised Newell Brands Inc. in its sale of The Waddington Group to Novolex Holdings, a portfolio company of The Carlyle Group, for approximately $2.3 billion in cash.
  • The Carlyle Group sells Signode Industrial Group Holdings to Crown Holdings, Inc. for $4 billionJones Day advised The Carlyle Group and its affiliates in connection with the sale of Signode Industrial Group Holdings (Bermuda) Ltd., a leading global provider of transit packaging systems and solutions, to Crown Holdings, Inc., a worldwide leader in the design, manufacture and sale of packaging products for consumer goods, for an aggregate purchase price of up to $4 billion.
  • J.M. Huber sells Silica business to Evonik for $630 millionJones Day advised J.M. Huber Corporation in the sale of its Silica business unit of Huber Engineered Materials to Evonik Industries AG for $630 million.
  • Baxter acquires Claris InjectablesJones Day served as antitrust counsel to Baxter International Inc. in its acquisition of generic pharmaceuticals company Claris Injectables Limited, a wholly owned subsidiary of Claris Lifesciences Limited.
  • GE sells GE Water & Process Technologies to Suez for $3.4 billionJones Day served as antitrust counsel to General Electric Company in the €3.2 billion ($3.4 billion) sale of GE Water & Process Technologies to Suez and Caisse de dépôt et placement du Québec.
  • USG sells L&W Supply Corporation to ABC Supply Co. for $670 millionJones Day advised USG Corporation in connection with its sale of L&W Supply Corporation, and certain other assets related to L&W's distribution business, to ABC Supply Co. Inc. for $670 million in cash.
  • Chiesi acquires three hospital products from The Medicines CompanyJones Day advised Chiesi Farmaceutici S.p.A., a pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets, in its acquisition of three cardiovascular products -- Kengreal® (cangrelor), Cleviprex® (clevidipine), and rights to Argatroban® for Injection –- from The Medicines Company.
  • Electrolux attempts acquisition of GE appliances businessJones Day represented Swedish appliance maker AB Electrolux as antitrust and labor counsel in its attempted $3.3 billion acquisition of the appliances business of General Electric.
  • Additional Publications

    • May 2021
      U.S. Antitrust Law Developments chapter in Report on Competition Law and Policy of China (2020), China World Trade Organization Studies
    • May 2020
      U.S. Antitrust Law Developments chapter in Report on Competition Law and Policy of China (2019), China World Trade Organization Studies
    • August 2018
      Structural Remedies, Global Competition Review, The Guide to Merger Remedies
    • April 9, 2018
      Chapter XII: Antitrust Division Relationships with State Attorneys General (contributing editor), DOJ Civil Antitrust Practice and Procedure Manual, Second Edition

    Speaking Engagements

    • May 6, 2020
      Co-Moderator, Lessons from the Field: The Evonik Litigation, W@ B3 Initiative